Pharmaceutical

Zyax Chem acquires 26% stake in Gaymed Labs

Investment brings board representation and expansion plans in ophthalmic segmen...

India’s biopharma moment—If we get the ecosystem right

Krishna Sarma highlights the ecosystem requirements for advancing biopharma inn...

UCB to purchase Neurona and NRTX-1001 for $1.15bn

The deal value comprises an upfront payment of up to $650m and up to $500m in fu...

MSD secures EC approval for Enflonsia to prevent infant...

This approval authorises Enflonsia’s marketing across all 27 European Union memb...

Clinical exclusivity for indigenous medicines can impro...

Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clin...

Morepen Laboratories clears fourth USFDA inspection at ...

Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing eng...

Rusan Pharma secures PMDA GMP approval for Ankleshwar a...

Approval from Japan regulator covers API and finished dosage manufacturing unit...

Aligos and Xiamen Amoytop sign deal for HBV therapy

This territory includes Hong Kong, Macau, Mainland China, and Taiwan. The focus ...

Daiichi Sankyo and Interna partner for MNM-targeted del...

The agreement involves Daiichi Sankyo Research Institute Boston and aims to asse...

Lupin subsidiary enters settlement agreement with Human...

Lupin Pharmaceuticals Inc to pay USD 30 million under agreement without admissi...

Aurobindo Pharma secures USFDA approval for Glycerol Ph...

Company to launch product for urea cycle disorders with market size of US$ 50....

Nucleai and Sirona Dx to provide new proteomics solutio...

The collaboration aims to bridge gaps between data generation and actionable ins...

Alembic Pharma gets USFDA nod for Methotrexate Injectio...

Methotrexate Injection is a folate analog metabolic inhibitor indicated for neo...

Boehringer Ingelheim and Zai Lab team up for dual DLL3 ...

This Phase Ib/II study will measure the tolerability, safety, and early clinical...

Rubicon Research acquires 85% stake in Arinna Lifesciences

Transaction valued at INR 200 crore to expand presence in CNS therapies and dom...

Adcendo secures $75m in Series C funding for ADC develo...

The financing will support Adcendo’s ongoing advancement of its first-in-class a...